Name the Active Product
Specify molecular form, assembly, topology, function, cofactors, and the product-related variants that matter.
Choose purification strategies around the physical and functional behavior of the biomolecule. This hub connects chromatography mechanisms with product-specific stability, impurities, analytical evidence, and workflow decisions from capture through final preparation.
Start with the Biomolecule, Not a Standard Column Sequence
Profile the Feed
Measure target, process impurities, particles, viscosity, endotoxin, and conditions that can change the target.
Use Orthogonal Mechanisms
Assign capture, intermediate purification, and polishing only where each step solves a defined separation problem.
Measure Usable Recovery
Close mass balance with activity, topology, stoichiometry, particle identity, or other product-specific quality evidence.
Match the Application to Its Primary Challenge
| Biomolecule | Primary purification challenge | Start here |
|---|---|---|
| Monoclonal antibodies | Capture plus aggregate, host impurity, and variant polishing | Antibody workflows |
| Fragments and bispecifics | Closely related assembly variants and dual function | Fragments and bispecifics |
| Recombinant enzymes | Preserving catalytic state, cofactors, and active yield | Active enzymes |
| Membrane proteins | Maintaining a stable protein–lipid–amphiphile complex | Membrane proteins |
| Extracellular vesicles | Separating EV-rich fractions from overlapping particles and soluble proteins | Extracellular vesicles |
| Plasmid DNA | Preserving topology while removing host nucleic acids and endotoxin | Plasmid DNA |
| Protein samples with endotoxin | Clearance without protein loss or assay masking | Endotoxin removal |
| Protein complexes | Maintaining stoichiometric, homogeneous assemblies | Protein complexes |
Use a product-specific denominator: report accepted antibody, active enzyme units, desired plasmid topology, EV-related recovery, or intact complex—not total absorbance alone.
A Six-Step Application Development Path
Define product stateIdentity, function, assembly, topology, cofactors, modifications, and stability.
Characterize feedTarget concentration, impurity families, particles, viscosity, and matrix effects.
Select mechanismsAffinity, charge, hydrophobicity, size, or partitioning matched to the critical separation.
Map fractionsFlow-through, wash, peak boundaries, rejected pools, strip, and transfer losses.
Confirm qualityFunction, identity, purity, structure, recovery, and downstream compatibility.
Scale and controlResidence time, load, mixing, holds, cleaning, storage, and transfer evidence.
Core Guides in This Topic
Each guide uses a different product-quality framework so the purification train reflects the actual biomolecule rather than a generic sequence.
Monoclonal Antibody Purification: From Capture to Polishing
Connect selective antibody capture with orthogonal impurity removal, quality-based pooling, and final polishing.
Purifying Antibody Fragments and Bispecific Antibodies
Match purification to domain architecture, assembly variants, dual functionality, and format-specific stability.
Recombinant Enzyme Purification: Preserving Catalytic Activity
Use catalytic activity, specific activity, cofactor state, and active yield to guide each purification decision.
Membrane Protein Purification: Detergents, Affinity Capture and SEC
Coordinate detergent extraction, affinity capture, amphiphile control, SEC, and structural homogeneity.
Extracellular Vesicle Purification by SEC: Recovery and Purity
Balance EV recovery against soluble-protein and particle contaminants using fraction-resolved SEC analytics.
Plasmid DNA Purification: Chromatography Strategy and Impurities
Preserve plasmid topology while removing RNA, genomic DNA, proteins, endotoxin, and process residues.
Endotoxin Removal from Protein Samples: Method Selection and Recovery
Select endotoxin-removal conditions that are measurable, robust, and compatible with protein recovery and function.
Purifying Protein Complexes for Structural Studies
Maintain assembly, stoichiometry, ligand state, and monodispersity for structure-ready protein complexes.
Mechanisms across Applications
| Mechanism | Best-supported role | Application-specific caution |
|---|---|---|
| Affinity | Selective capture through a tag, domain, or ligand | Binding may not distinguish assembly variants |
| Ion exchange | Capture, polishing, flow-through impurity removal | Charge predictions require empirical confirmation |
| Hydrophobic or multimodal | Orthogonal separation of surface variants | Stability and reversible recovery can limit use |
| Size exclusion | Nonbinding fractionation and homogeneity polishing | Load volume, dilution, and overlapping sizes limit resolution |
| Partition or selective adsorption | Specialized endotoxin or impurity removal | Residual reagents and product loss require control |
Products and Purification Support
Chromatography Materials
Project Support
Share the biomolecule state, feed, critical impurities, analytical methods, scale, and required final buffer when discussing project scope.
Reading Paths by Development Need
Protein Therapeutics and Reagents
Begin with antibody workflows, engineered antibody formats, or active enzymes. Add endotoxin removal when the residual burden and intended use require a focused strategy.
Particles, Nucleic Acids, and Structural Samples
Use membrane-protein purification, EV fractionation, plasmid DNA chromatography, or protein-complex preparation to connect purification with the relevant physical state.
Plan a biomolecule-specific purification workflow
Share the target, feed, current purity, critical impurities, stability limits, scale, and required final state to frame a focused development plan.
References
- Carta G, Jungbauer A. Protein Chromatography: Process Development and Scale-Up. 2nd edition. Wiley-VCH; 2020. doi:10.1002/9783527824045
- ICH. Q6B: Specifications—Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. 1999.
